Kaiser Permanente Vaccine Study CenterOakland, California, United States
Disclosure(s): No financial relationships to disclose
517 - Maternal RSV Vaccination and Infant Nirsevimab Coverage among Infants Born in the 2023-2024 Respiratory Virus Season in a Large Integrated Healthcare System
Saturday, October 19, 202411:00 AM – 11:15 AM US PT